Nanogenecs is a Cambridge, Massachusetts-based company founded in 2016 by Alexis Vallée-Bélisle.
Nanogenecs is an early stage in vitro diagnostic company enabling patients with chronic diseases to manage their conditions through a platform for remote self-testing that yields equivalent results to the central lab.